Aging Boomers: A Perfect Tailwind for Genomics Stocks Posted by Adam O'Dell | May 27, 2021 | Investing Aging baby boomers are a decades-long tailwind for genomics stocks as scientists develop DNA-based medicine to fight prolific diseases. Read More
Biotech Barbell: The Best Way to Invest in a “Risky” Sector Posted by Adam O'Dell | May 21, 2021 | Investing Investing in a segment like biotech doesn’t have to feel risky. The “barbell” strategy creates a balance between high- and low-risk assets. Read More
Bigger Than the Internet: DNA Will Lead the Next Stock Market Wave Posted by Adam O'Dell | May 18, 2021 | Markets The DNA revolution is here, and I think it has the potential to be more impactful than the internet across multiple stock sectors. Read More
A Biotech Co.’s Journey from Small- to Mid-Cap — and Beyond Posted by Adam O'Dell | May 17, 2021 | Investing A stock’s size factor relates to its market capitalization, and it explains in part how smaller companies can lead to huge stock market gains. Read More
Will Biden’s Tax Hike Scare Big Money Out of the Markets? Posted by Adam O'Dell | May 10, 2021 | Markets You might be wondering what President Biden’s capital gains tax would do to the stock market. Here’s how I think big investors will react. Read More